Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Efficacy of Behavioral Approaches for Treatment of Insomnia (CEBATI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03461666
Recruitment Status : Recruiting
First Posted : March 12, 2018
Last Update Posted : September 30, 2020
Sponsor:
Information provided by (Responsible Party):
Pacific Institute of Medical Sciences

Brief Summary:
This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I); Focus of Attention (FOA); Combined CBT-I and FOA; and Sleep Hygiene (control group) for the treatment of insomnia. This study is a randomized, open label study, and the participants are asked to assess the benefits they get from the intervention. This study involve 6 weekly in person one-to-one sessions after screening and completion of the 1-week, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administering the treatment. The Research Department will administer the outcome measures. The review of insomnia improvement will be assessed at at end of treatment, 3 months, 6 months and 12 months follow-up.

Condition or disease Intervention/treatment Phase
Primary Insomnia Behavioral: Cognitive Behavior Therapy-Insomnia Behavioral: Focus of Attention Behavioral: Combined-CBT-I and FOA Group Behavioral: Sleep Hygiene Not Applicable

Detailed Description:

This study compares the efficacy of four different types (Cognitive Behavior Therapy for Insomnia (CBT-I), Focus of Attention (FOA), Combined CBT-I and FOA and Sleep Hygiene) of therapies approaches for the treatment of insomnia. This study is a randomized, open label study, the participants are asked to review the benefits they get from the intervention. This study involve 6 weekly sessions after screening and completion of the end of treatment, 3-month, 6-month and 12-month follow-up assessment. The trained study staff will administer study scales during therapy session. The subjective review of insomnia improvement will be assessed at end of treatment, 3 months, 6 months and 12 months follow-up assessment. Subjects are adult who meet, DSM-5 the diagnostic criteria for primary Insomnia.

Inclusion/Exclusion criteria to be assessed at Screening (Visit 1) and Visit 2. For those found eligible who complete the study, participation will include Screening (Visit 1), 6 weekly sessions after screening, and completion of the post-treatment and 6-month followup assessment.

Once subject sign the consent form, subject will be asked inclusion and exclusion criteria and will be given details about the study as per protocol.

Those eligible will be randomly assigned to one of four behavioral treatment approaches. The participant will have six weekly one hour in person sessions in which the assigned treatment will be administered. The participant will be assessed at the end of treatment and again at 6 month followup.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 160 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: parallel group
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: A Randomized, Open Label, Sleep Hygiene Controlled 6-Week Study to Compare the Efficacy of Four (CBT-I, FOA, Combined CBT-I and FOA and Sleep Hygiene) Different Behavioral Approaches for the Treatment of Adult Subjects With Insomnia
Actual Study Start Date : September 5, 2018
Estimated Primary Completion Date : November 1, 2021
Estimated Study Completion Date : July 1, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Healthy Sleep

Arm Intervention/treatment
Active Comparator: Cognitive Behavior Therapy-Insomnia
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral: Cognitive Behavior Therapy-Insomnia
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Focus of Attention
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Combined-CBT-I and FOA Group
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Sleep Hygiene
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Active Comparator: Focus Of Attention
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral: Cognitive Behavior Therapy-Insomnia
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Focus of Attention
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Combined-CBT-I and FOA Group
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Sleep Hygiene
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Active Comparator: Combined-CBT-I and FOA Group
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral: Cognitive Behavior Therapy-Insomnia
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Focus of Attention
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Combined-CBT-I and FOA Group
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Sleep Hygiene
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Active Comparator: Sleep Hygiene
Participants receive 6 one hour in person behavioral psycho-intervention sessions from a treatment provider.
Behavioral: Cognitive Behavior Therapy-Insomnia
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Focus of Attention
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Combined-CBT-I and FOA Group
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.

Behavioral: Sleep Hygiene
Behavioral Psycho-intervention education therapy.Face to Face, Six sessions, one hour each.




Primary Outcome Measures :
  1. Self Report Sleep Measures [ Time Frame: through study completion, an average of 1 year ]
    SRSM: assess overall quantity of sleep satisfaction on the Self Report Sleep Measures.


Secondary Outcome Measures :
  1. Insomnia Severity Index [ Time Frame: through study completion, an average of 1 year ]
    ISI: assess the severity of insomnia.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 72 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male and female outpatients who are 18 or older to 72 years. Insomnia Severity Index > or = 10
  • Meet diagnostic criteria for Insomnia Disorder per DSM-5 Willing and able to sign Informed consent form Not planning on moving away from the area for the subsequent 12 weeks.

Exclusion Criteria:

  • Participants who answer "yes" to any of the following will be excluded:
  • Females who are lactating or who are pregnant
  • Night shift workers, and individuals who nap 3 or more times per week over the preceding month
  • Consumption of caffeine beverages (i.e. tea, coffee, or cola) comprising usually more than 5 cups or glasses per day
  • Participation in another trial for insomnia
  • Persons unable to complete the study questionnaires and psychological tests
  • Persons who are unable to participate for the entire duration of the study, or in the opinion of the investigators, are likely to be non-compliant with the obligations inherent in the trial participation
  • Persons self-describing with severe anxiety or severe depression (BDI score of 29 or higher) or severe anxiety (BAI score of 36 or higher).
  • Persons with a history of epilepsy, seizures, or dementia
  • Any significant, severe or unstable, acute or chronically progressive medical or surgical condition
  • Serious head injury or stroke within the past year
  • Current alcohol or substance abuse/dependence (must have >90 days of sobriety)
  • Presence of other neurological disorders (e.g., multiple sclerosis, Parkinson's Disease)
  • Presence of an untreated or unstable medical or psychiatric comorbid condition (e.g., major depressive disorder or psychotic disorder requiring admission within the last two years). People using psychotropic medication, hypnotic or sedative medications may be included if they are on a stable dosage for the last 2 months prior to the study, if the dose remains stable throughout the study, and if the medication is judged to not interfere with the study outcomes.
  • Currently on medications known to produce insomnia (e.g., stimulants)
  • Sleep apnea (AHI >15) or previous diagnosis of sleep apnea. Study participants who use a continuous positive airway pressure (CPAP) device for sleep apnea will be eligible for participation if they are below the apnea/hypopnea cutoff while using CPAP and agree to use the device during study participation.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03461666


Contacts
Layout table for location contacts
Contact: Max Hines, Ph.D 425-949-5779/ 425-223-2304 max@pspc.org
Contact: Syed Mustafa, M.D 425-806-5021 sjmustafamd@pspc.org

Locations
Layout table for location information
United States, Washington
Puget Sound Psychiatric Center Enrolling by invitation
Bothell, Washington, United States, 98011
Puget Sound Psychiatry Center Recruiting
Bothell, Washington, United States, 98011
Contact: Max Hines, Ph.D    425-949-5779    max@pspc.org   
Contact: Syed Mustafa, M.D    425-806-5021    sjmustafamd@pspc.org   
Principal Investigator: Max Hines, Ph.D         
Sponsors and Collaborators
Pacific Institute of Medical Sciences
Investigators
Layout table for investigator information
Principal Investigator: Max Hines, Ph.D Puget Sound Psychiatry center
  Study Documents (Full-Text)

Documents provided by Pacific Institute of Medical Sciences:
Study Protocol  [PDF] February 12, 2018
Informed Consent Form  [PDF] September 23, 2020

Publications of Results:
Layout table for additonal information
Responsible Party: Pacific Institute of Medical Sciences
ClinicalTrials.gov Identifier: NCT03461666    
Other Study ID Numbers: PSPC-17-01
First Posted: March 12, 2018    Key Record Dates
Last Update Posted: September 30, 2020
Last Verified: September 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Finding to present in peer review journals

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Pacific Institute of Medical Sciences:
Primary insomnia
Behavioral treatment of primary insomnia
Focus of attention
cognitive behavioral therapy for insomnia
Additional relevant MeSH terms:
Layout table for MeSH terms
Sleep Initiation and Maintenance Disorders
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases
Mental Disorders